Category: by publisher

After 35 years, philosophy journal corrects article…by a cat

A cat philosopher, via Pixabay

In 1982, Bruce Le Catt wrote a response to a paper in the Australasian Journal of Philosophy critiquing an earlier article about prosthetic vision.

But Le Catt was no ordinary author. No, he was a cat, the beloved pet of David Lewis, a world-class philosopher who just happened to be the author of the article about which Bruce Le Catt was commenting.

Lewis’ inside joke wasn’t lost on those who knew him, and the benign deception seems to have been common knowledge in the field since the Le Catt paper appeared in 1982 (which also happens to be the year Cats began its run on Broadway). The paper has been cited four times since it was published, according to Clarivate Analytics. But 25 years later, the journal has finally decided to put an end to the gag.

The joyless notice states plainly: Continue reading After 35 years, philosophy journal corrects article…by a cat

After investigation that started at least 5 years ago, retired ob-gyn prof agrees to 5 years of supervision

Nasser Chegini

A now-retired professor tweaked the findings in seven figures of a 2007 paper, according to a new finding of misconduct released yesterday by the U.S. Office of Research Integrity.

The subject of the findings isn’t a stranger to our readers: We’ve already reported on nine retractions for Nasser Chegini, a former professor of obstetrics and gynecology at the University of Florida (UF) who had won more than $4 million in Federal grants. And Chegini, who retired in early 2012, had been under investigation since at least 2012, with the ORI asking UF to broaden that investigation at one point.

Indeed, the ORI’s notice states that eight of Chegini’s retractions resulted from the UF’s investigation. The ORI’s findings, however, stem from another paper, published in the Journal of Reproductive Immunology, which has not been retracted.

According to the ORI, in that paper, Chegini:

Continue reading After investigation that started at least 5 years ago, retired ob-gyn prof agrees to 5 years of supervision

Researcher who stole manuscript during peer review earns second retraction

The researcher whose brazen theft of a manuscript he had reviewed prompted a “Dear plagiarist” letter from the aggrieved author once the deceit was discovered has lost a second paper for plagiarism.

International Scholarly Research Notices, a Hindawi publication, has retracted a 2012 study by Carmine Finelli and colleagues, citing widespread misuse of text from two previously published articles. The removal was prompted by the curiosity of a scientist in England who, on reading about Finelli’s first retraction, made the logical assumption: once a plagiarist, often a plagiarist.

The review article was titled “Physical Activity: An Important Adaptative Mechanism for Body-Weight Control.” The journal is not indexed by Clarivate Analytics’ Web of Science, but the paper has been cited seven times, according to Google Scholar. According to the retraction notice: Continue reading Researcher who stole manuscript during peer review earns second retraction

Study of social media retracted when authors can’t provide data

A business journal has retracted a 2016 paper about how social media can encourage young consumers to become devoted to particular brands, after discovering flaws in the data and findings.

The paper—published in South Asian Journal of Global Business Research, now called South Asian Journal of Business Studies—was retracted in June 2017, after the journal learned of flaws that called the “validity of the data and reported findings” into question.

Here’s the retraction notice for “Evaluating the influence of social media on brand sacralization: an empirical study among young online consumers”: Continue reading Study of social media retracted when authors can’t provide data

Journal retracts paper it says authors published twice. Authors disagree.

A journal has retracted a 2012 paper after determining that the authors had already published it elsewhere.

According to the retraction notice, the editors-in-chief of the Journal of Occupational Medicine and Toxicology concluded that the article had  been published in another journal—In Vitro Cellular & Developmental Biology – Animal—the previous month. The authors, however, did not agree to the retraction.

The research, led by Ali Khavanin, who is based at Tarbiat Modares University in Tehran, Iran and is corresponding author on both papers, evaluated whether the vibrations from industrial machinery can harm hearing in rabbits (1, 2).

Here’s the retraction notice for “Assessment of the influence of whole body vibration on Cochlear function”: Continue reading Journal retracts paper it says authors published twice. Authors disagree.

Why did it take a journal two years to retract a paper after a misconduct finding?

A 2014 paper containing data manipulated by a former graduate student has finally been retracted, two years after the U.S. Office of Research Integrity (ORI) published its findings.

In August 2015, the ORI published a report that Peter Littlefield, who was working on his PhD at the University of California, San Francisco (UCSF), had committed “research misconduct by falsifying and/or fabricating data” in two papers. Littlefield agreed to correct or retract the papers–one published in Chemistry & Biology and the other in Science Signaling.  

When we contacted Chemistry & Biology back in August 2015, a spokesperson for Cell Press told us the journal was figuring out “the best way to correct the scientific record.”

Apparently that took two years. In the meantime, the journal did not issue an expression of concern or otherwise notify readers of the issues. Continue reading Why did it take a journal two years to retract a paper after a misconduct finding?

Controversial CRISPR paper earns second editorial note

Against the authors’ objections, Nature Methods has added an expression of concern to a 2017 paper that drew fire for suggesting a common gene editing technique could cause widespread collateral damage to the genome. The latest note — the second to be added in two months — alerts readers to an alternative interpretation of the findings.

When “Unexpected mutations after CRISPR–Cas9 editing in vivo” was published May 30, it immediately drew criticism from many of the top scientists working with CRISPR, including those associated with companies seeking to develop CRISPR-based therapies for humans. Share prices for the two largest companies pursuing CRISPR therapies, Editas Medicine and Intellia Therapeutics, dropped following publication of the article.

On June 14, the journal published a notice to alert readers to “technical criticisms” of the paper. Apparently, that wasn’t sufficient, because the journal is now providing more details on the nature of the criticisms, despite the objections of the paper’s authors:

Continue reading Controversial CRISPR paper earns second editorial note

Uni dings schizophrenia studies for problems with informed consent, other flaws

Psychiatry journals have retracted two papers evaluating a schizophrenia drug after a university in Japan flagged issues, such as a lack of written informed consent.

The papers—published in Human Psychopharmacology: Clinical & Experimental in 2012 and Psychiatry and Clinical Neurosciences in 2014—examined the safety and effectiveness of an antipsychotic drug in patients with schizophrenia.

According to the retraction notice in Psychiatry and Clinical Neurosciences, the ethics committee at St. Marianna University School of Medicine in Kawasaki found that “the trial included subjects who did not satisfy inclusion criteria.” For instance, not all patients provided written informed consent. But the university found no evidence for data falsification or fabrication.

A spokesperson for Human Psychopharmacology told us: Continue reading Uni dings schizophrenia studies for problems with informed consent, other flaws

Following uproar, surgery journal retracts paper with male-only pronouns

The Annals of Surgery has retracted a paper that used only male pronouns to describe surgeons following outcry from readers.

The journal plans to replace the article — a recent presidential address of the European Surgical Association — with a new version with more “gender inclusive language.”

The problem, said editor Keith D. Lillemoe, is that the address was delivered in April by previous ESA president Marek Krawczyk in Polish. According to an email Krawczyk sent to ESA leadership, which Lillemoe forwarded to us, Krawczyk says the pronoun “his” can include women in Polish.

Still, Lillemoe told us, the journal believed it needed to quickly retract the paper:

Continue reading Following uproar, surgery journal retracts paper with male-only pronouns

Work by group at Australian university faces scrutiny

A journal is investigating research by a group in Australia, after receiving “serious allegations” regarding a 2017 paper about treating eye burns.

The journal, Frontiers in Pharmacology, has issued an expression of concern (EOC) for the 2017 paper while it investigates. The notice does not specify the nature of the allegations.  Meanwhile, several other papers by the three researchers, based at Deakin University in Geelong, Australia, have also come under scrutiny. Late last month, Frontiers in Pharmacology retracted a 2015 paper by Kislay Roy, Rupinder Kanwar, and Jagat R Kanwar, citing image duplication. A 2015 paper in Biomaterials received a correction in May 2017, again flagging image duplication.

Roy, the first author on the papers, is a postdoctoral research fellow; Rupinder Kanwar, a middle author, is a senior lecturer; and Jagat R Kanwar, the corresponding author on all three, is head of the Nanomedicine-Laboratory of Immunology and Molecular Biomedical Research.

Gearóid Ó Faoleán, the ethics and integrity manager at Frontiers in Pharmacology, explained that the investigation into the flagged article is ongoing and the EOC “must serve as the extent of our public statement for the present.”

A spokesperson for Deakin University declined to comment on the allegations: Continue reading Work by group at Australian university faces scrutiny